Deutsch

enlarged text

ABOUT LUX

Lux Biosciences is a clinical stage biotechnology company specialized in the field of ophthalmic diseases.
We are developing novel medications to treat the underlying causes of ophthalmic diseases and alleviate their symptoms, and if these products are approved by regulatory authorities, we intend to commercialize them.
With two first-in-class products currently in Phase 3 clinical development and several innovative, highly promising earlier stage projects, we have made significant progress towards building a revenue-generating, high-growth, and sustainable ophthalmic company.